Cargando...
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
Neuroendocrine tumors are a rare and heterogeneous group of tumors with a variety of primary origins and variable aggressiveness. Platinum-based chemotherapy has been the cornerstone of treatment for the poorly differentiated tumors. However, well-differentiated neuroendocrine tumors are quite chemo...
Gardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4755420/ https://ncbi.nlm.nih.gov/pubmed/26929640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S72155 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|